Congo vs Trinidad and Tobago: Prevalence rate of hypertension in women aged 30-79
Congo
41.5
in 2019
Trinidad and Tobago
41.6
in 2019
Congo rank
58th
Trinidad and Tobago rank
56th
Prevalence rate of hypertension in women aged 30-79 over time
- Congo
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 41.6 against 41.5 in Congo, a difference of 0.1.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Congo ahead.
Congo ranks 58th and Trinidad and Tobago ranks 56th of 195 countries.
Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 38.48 | 33.61 | 4.87 | Congo |
| 2000s | 40.59 | 36.12 | 4.47 | Congo |
| 2010s | 41.64 | 40.29 | 1.35 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Congo or Trinidad and Tobago?
- Trinidad and Tobago, at 41.6 against 41.5 in Congo as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Congo and Trinidad and Tobago?
- 0.1, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Congo and Trinidad and Tobago?
- 30 years are reported by both, from 1990 to 2019.
- How do Congo and Trinidad and Tobago rank globally for prevalence rate of hypertension in women aged 30-79?
- Congo ranks 58th and Trinidad and Tobago ranks 56th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.